Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma

Clinical trial NCT06528847 · RECRUITING

Trial details

NCT number: NCT06528847
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2024-06-05
Primary completion: 2027-06-30
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.